Using nanostring gene expression analysis we first confirmed that SCC6.2 cells have a similar expression profile of Major Histocompatibility Complex (MHC) molecules to that of CD80+ SCC7.1 cells that respond to BI 853520 (Figure 2F), ensuring that SCC6.2 cells express MHC-I molecules required for CD8 T-cell recognition and effective anti-tumor immunity. This evidence concerns the gene CD8A and neoplasm.